Attached files

file filename
S-1/A - AMENDMENT NO.1 TO FORM S-1 - NovoCure Ltdd940664ds1a.htm
EX-10.16 - EX-10.16 - NovoCure Ltdd940664dex1016.htm
EX-3.3 - EX-3.3 - NovoCure Ltdd940664dex33.htm
EX-1.1 - EX-1.1 - NovoCure Ltdd940664dex11.htm
EX-3.5 - EX-3.5 - NovoCure Ltdd940664dex35.htm
EX-10.15 - EX-10.15 - NovoCure Ltdd940664dex1015.htm
EX-21.1 - EX-21.1 - NovoCure Ltdd940664dex211.htm
EX-10.14 - EX-10.14 - NovoCure Ltdd940664dex1014.htm
EX-3.4 - EX-3.4 - NovoCure Ltdd940664dex34.htm
EX-5.1 - EX-5.1 - NovoCure Ltdd940664dex51.htm
EX-10.5 - EX-10.5 - NovoCure Ltdd940664dex105.htm
EX-10.12 - EX-10.12 - NovoCure Ltdd940664dex1012.htm
EX-10.17 - EX-10.17 - NovoCure Ltdd940664dex1017.htm
EX-4.1 - EX-4.1 - NovoCure Ltdd940664dex41.htm
EX-10.18 - EX-10.18 - NovoCure Ltdd940664dex1018.htm

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 24, 2015 (except for Notes 9, 13, 15, 18, as to which the date is September 21, 2015) in the Registration Statement (Form S-1, No. 333-206681) and the related Prospectus of NovoCure Limited dated September 21, 2015.

 

September 21, 2015    

/s/ Kost Forer Gabbay & Kasierer

 

Kost Forer Gabbay & Kasierer

Tel-Aviv, Israel     A Member of Ernst & Young Global